Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 185 Records) |
Query Trace: Leukemia and EFS[original query] |
---|
Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20-a very high-risk subtype in B-cell acute lymphoblastic leukemia. Bone marrow transplantation 2022 9 57 (12): 1751-1757. Tang Bingqing, Cai Zihong, Wang Zhixiang, Lin Dainan, He Xianjun, Li Qiuli, Liang Xiaojie, Huang Kangyu, Zhou Xuan, Lin Ren, Xu Na, Fan Zhiping, Huang Fen, Sun Jing, Liu Xiaoli, Liu Qifa, Zhou Hongshe |
Clinical implications and genetical insights of SOX6 expression in acute myeloid leukemia. Journal of cancer research and clinical oncology 2022 9 . Li Yan, Jiang Duanfeng, Zhang Qin, Liu Enyi, Shao Haiga |
Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study. Biology 2022 6 11 (6): . Corley Elizabeth M, Mustafa Ali Moaath K, Alharthy Hanan, Kline Kathryn A F, Sewell Danielle, Law Jennie Y, Lee Seung Tae, Niyongere Sandrine, Duong Vu H, Baer Maria R, Emadi Ashk |
Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes. Frontiers in oncology 2022 6 12 878098. Feng Jing, Guo Ye, Yang Wenyu, Zou Yao, Zhang Li, Chen Yumei, Zhang Yingchi, Zhu Xiaofan, Chen Xiaoju |
Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing. Frontiers in oncology 2022 3 12 811151. Yin Hua, Hong Mei, Deng Jun, Yao Lan, Qian Chenjing, Teng Yao, Li Tingting, Wu Qiuli |
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation. Blood cancer journal 2022 12 12 (12): 170. Jentzsch Madlen, Bischof Lara, Ussmann Jule, Backhaus Donata, Brauer Dominic, Metzeler Klaus H, Merz Maximilian, Vucinic Vladan, Franke Georg-Nikolaus, Herling Marco, Platzbecker Uwe, Schwind Sebasti |
Evaluating the clinical significance of FLT3 mutation status in Syrian newly diagnosed acute myeloid leukemia patients with normal karyotype. Heliyon 2022 12 8 (11): e11858. Moualla Yahia, Moassass Faten, Al-Halabi Bassel, Al-Achkar Walid, Georgeos Michael, Yazigi Haissam, Khamis Ati |
Molecular characterization of AML-MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC-defining criteria, TP53 allelic state, or TP53 variant allele frequency. Cancer medicine 2022 11 . Zhao Davidson, Eladl Entsar, Zarif Mojgan, Capo-Chichi José-Mario, Schuh Andre, Atenafu Eshetu, Minden Mark, Chang Ho |
Clinical characteristics and prognostic analysis of acute myeloid leukemia patients with PTPN11 mutations. Hematology (Amsterdam, Netherlands) 2022 11 27 (1): 1184-1190. Sun Yueyue, Zhang Fenghong, Huo Li, Cai Wenzhi, Wang Qinrong, Wen Lijun, Yan Lingzhi, Shen Hongjie, Xu Xiaoyu, Chen Suni |
Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia. Blood cancer journal 2022 10 12 (10): 144. Bidikian Aram, Kantarjian Hagop, Jabbour Elias, Short Nicholas J, Patel Keyur, Ravandi Farhad, Sasaki Koji, Issa Ghayas |
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study. Blood advances 2022 10 7 (2): 196-204. Aldoss Ibrahim, Yin Jun, Wall Anna, Mrózek Krzysztof, Liedtke Michaela, Claxton David F, Foster Matthew C, Appelbaum Frederick R, Erba Harry P, Litzow Mark R, Tallman Martin S, Stone Richard M, Larson Richard A, Advani Anjali S, Stock Wendy, Luger Selina |
Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia-Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022. Cancers 2023 9 15 (18): . Ma?gorzata Czoga?a, Wojciech Czoga?a, Katarzyna Pawi?ska-W?sikowska, Teofila Ksi??ek, Karolina Bukowska-Strakova, Barbara Sikorska-Fic, Pawe? ?aguna, Anna Fa?kowska, Katarzyna Drabko, Katarzyna Muszy?ska-Ros?an, Maryna Krawczuk-Rybak, Marta Koz?owska, Ninela Irga-Jaworska, Karolina Zielezi?ska, Tomasz Urasi?ski, Natalia Bartoszewicz, Jan Styczy?ski, Jolanta Skalska-Sadowska, Jacek Wachowiak, Anna Rodziewicz-Konarska, Krzysztof Ka?wak, Ma?gorzata Ciebiera, Rados?aw Chaber, Agnieszka Mizia-Malarz, Agnieszka Choda?a-Grzywacz, Gra?yna Karolczyk, Katarzyna Bobeff, Wojciech M?ynarski, Katarzyna Mycko, Wanda Badowska, Renata Tomaszewska, Tomasz Szczepa?ski, Katarzyna Machnik, Natalia Zamorska, Walentyna Balwierz, Szymon Skocz |
PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia. Aging 2023 7 15 . Ling Wang, Chuang Jiang, Dandan |
The Prognostic Value of TP53 Mutations in Adult Acute Myeloid Leukemia: A Meta-Analysis. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2023 7 50 (3): 234-244. Guoxiang Qin, Xueling H |
TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation. Cancers 2023 6 15 (12): . Davidson Zhao, Mojgan Zarif, Qianghua Zhou, José-Mario Capo-Chichi, Andre Schuh, Mark D Minden, Eshetu G Atenafu, Rajat Kumar, Hong Cha |
[Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (3): 222-229. D Feng, M Y Wang, J Liu, H X Zhang, X Chen, R L Zhang, W H Zhai, Q L Ma, A M Pang, D L Yang, J L Wei, Y He, S Z Feng, M Z Han, E L Jia |
Phase 1/2 Study of Sorafenib Added to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone in Untreated AML. Blood advances 2023 6 . Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival, Ryan D Cassaday, Vivian G Oehler, Pamela S Becker, Jacob Appelbaum, Janis L Abkowitz, Johnnie J Orozco, Sioban B Keel, Paul Hendrie, Bart L Scott, Cristina Maria M Ghiuzeli, Elihu Estey, Roland B Walt |
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis. Blood advances 2023 6 . Sara Zarnegar-Lumley, Todd Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E Ries, Jim Wang, Amanda R Leonti, Matthew A Kutny, Fabiana Ostronoff, Jerald P Radich, Frederick R Appelbaum, Era L Pogosova-Agadjanyan, Kristen M O'Dwyer, Martin S Tallman, Mark R Litzow, Ehab Atallah, Todd M Cooper, Richard Aplenc, Omar I Abdel-Wahab, Alan S Gamis, Selina M Luger, Harry P Erba, Ross L Levine, E Anders Kolb, Derek L Stirewalt, Soheil Meshinchi, Katherine Tarlo |
Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group. Cancer medicine 2023 5 . Minhui Zeng, Keke Chen, Xin Tian, Runying Zou, Xiaoqin Feng, Chunfu Li, Jian Li, Mincui Zheng, Huirong Mai, Lihua Yang, Yingyi He, Honggui Xu, Hong Wen, Xiangling |
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome. Blood cancer journal 2023 5 13 (1): 88. Julia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, Sven Zukunft, Marita Hartwig, Christoph Röllig, Jan Moritz Middeke, Uta Oelschlägel, Utz Krug, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Mathias Hänel, Richard Noppeney, Ulrich Kaiser, Claudia D Baldus, Martin Kaufmann, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Frank Kroschinsky, Christian Thiede, |
TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia. Genes, chromosomes & cancer 2023 4 . Yusuke Hara, Norio Shiba, Kenichi Yoshida, Genki Yamato, Taeko Kaburagi, Yuichi Shiraishi, Kentaro Ohki, Yusuke Shiozawa, Machiko Kawamura, Hirohide Kawasaki, Manabu Sotomatsu, Takumi Takizawa, Hidemasa Matsuo, Akira Shimada, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Etsuro Ito, Keizo Horibe, Satoru Miyano, Souichi Adachi, Tomohiko Taki, Seishi Ogawa, Yasuhide Hayas |
A comprehensive analysis of cytogenetics, molecular profile, and survival among pediatric acute myeloid leukemia: a prospective study from a tertiary referral center. American journal of blood research 2023 2 12 (6): 177-189. Meena Jagdish Prasad, Makkar Harshita, Gupta Aditya Kumar, Bakhshi Sameer, Gupta Ritu, Thakral Deepshi, Chopra Anita, Tanwar Pranay, Upadhyay Ashish Datt, Pathak Nivedita, Seth Rach |
Prognostication refinement in NPM1-mutated acute myeloid leukemia stratified by FLT3-ITD status with different induction doses of cytarabine. Cancer medicine 2023 2 . Wang Biao, Hua Xiaoying, Zhang Jihong, Gu Weiying, Li Haiqi |
[Clinical Study on the Relationship between Gene Mutation Profile and Prognosis in Pediatric Acute Lymphocyte Leukemia]. Zhongguo shi yan xue ye xue za zhi 2023 2 31 (1): 17-24. Chen Yan, Qi Shan-Shan, Ding Li-Li, DU Yu, Song Na, Wang Zhuo, Yang Li, Sun Ming, Xiong H |
Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer. JAMA network open 2023 12 6 (12): e2348814. Paola Zagami, Aranzazu Fernandez-Martinez, Naim U Rashid, Katherine A Hoadley, Patricia A Spears, Giuseppe Curigliano, Charles M Perou, Lisa A Car |
Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation. Pharmacogenomics and personalized medicine 2023 11 16 1011-1026. Rui Huang, Yi-Ting Zhang, Yu Lin, Ru-Li Pang, Zhi Yang, Wei-Hua Zh |
A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia. Annals of hematology 2024 1 . Juanjuan Song, Weiya Li, Yanliang Bai, Pan Zhou, Junwei Niu, Xiaona Niu, Ying Liu, Xiaobo Liu, Emmanuel Kwateng Drokow, Kai Sun, Hu Zh |
A multi-center retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML. Blood advances 2024 1 . Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi, Weiyan Zheng, Qian Jiang, Hongying Chao, Peifang Xiao, Weijuan Yu, Yanqiu Han, Yu Wu, Yan Zeng, Depei Wu, Xiaofei Yang, Suning Ch |
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 2024 1 14 (1): 15. Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor-Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Ti |
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 1 . Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward A Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder K Lam |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: